Skip to Main Content

Author Details

Kouros Owzar
Duke University
2005
140
34
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37577619SifiNet: A robust and accurate method to identify feature gene sets and annotate cells.bioRxiv2024
38014869DYNATE: Localizing rare-variant association regions via multiple testing embedded in an aggregation tree.Genet Epidemiol2024
37129971Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD.JCI Insight2023
37956617High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer.Gynecol Oncol2023
38051771The TLR2/TLR6 ligand FSL-1 mitigates radiation-induced hematopoietic injury in mice and nonhuman primates.Proc Natl Acad Sci U S A2023
37433282Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2023
34312214Clinical Trials with Biologic Primary Endpoints in Immuno-oncology: Concepts and Usage.Clin Cancer Res2022
35668193P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.Nat Cancer2022
36400020Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell2022
36575517Clustering Deviation Index (CDI): a robust and accurate internal measure for evaluating scRNA-seq data clustering.Genome Biol2022
36274097Leveraging patient derived models of FGFR2 fusion positive intrahepatic cholangiocarcinoma to identify synergistic therapies.NPJ Precis Oncol2022
34855933Re-Examination of the Exacerbating Effect of Inflammasome Components during Radiation Injury.Radiat Res2022
34853435Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
34965954Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).Clin Cancer Res2022
34645983Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestry.Prostate Cancer Prostatic Dis2022
34616010Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
34528705Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.Int J Cancer2022
34795033APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.Cancer Immunol Res2022
32958699Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).Clin Cancer Res2021
33829609Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).Oncologist2021
33705884Differential alternative RNA splicing and transcription events between tumors from African American and White patients in The Cancer Genome Atlas.Genomics2021
34518880Comparative analysis of RNA enrichment methods for preparation of Cryptococcus neoformans RNA sequencing libraries.G3 (Bethesda)2021
34538531Obesity and altered angiogenic-related gene expression in endometrial cancer.Gynecol Oncol2021
34149004Pharmacogenetic study in gastric cancer patients treated with adjuvant fluorouracil/leucovorin or epirubicin/cisplatin/fluorouracil before and after chemoradiation on CALGB 80101 (Alliance).Pharmacogenet Genomics2021
34035082Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.Cancer Res2021
33951180A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.Cancer2021
33465699RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.Lung Cancer2021
33445417DNA-Damage-Induced Alternative Splicing of p53.Cancers (Basel)2021
32293745Predictive accuracy of markers or risk scores for interval censored survival data.Stat Med2020
31919136Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.Clin Cancer Res2020
31918995Differential expression of immune related genes in high-grade ovarian serous carcinoma.Gynecol Oncol2020
33335088Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy.Nat Commun2020
33024122Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence.Nat Commun2020
32747417Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.Mol Cancer Ther2020
32436503Plasmonic nanobiosensors for detection of microRNA cancer biomarkers in clinical samples.Analyst2020
32325171Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma.Biol Blood Marrow Transplant2020
32562552Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.Clin Pharmacol Ther2020
32561656The Long Noncoding RNA <i>NEAT1</i> Promotes Sarcoma Metastasis by Regulating RNA Splicing Pathways.Mol Cancer Res2020
30443898SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia.Br J Haematol2019
30260474A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance).Clin Pharmacol Ther2019
31212080A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance).Biol Blood Marrow Transplant2019
31195980fastJT: An R package for robust and efficient feature selection for machine learning and genome-wide association studies.BMC Bioinformatics2019
30889042An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance).Pharmacogenet Genomics2019
31112524Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.JCI Insight2019
30759098Late effects of total body irradiation on hematopoietic recovery and immune function in rhesus macaques.PLoS One2019
31138120Efficient estimation of grouped survival models.BMC Bioinformatics2019
29168174Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk.Int J Cancer2018
30107003The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.PLoS One2018
29888484Sample size calculation for studies with grouped survival data.Stat Med2018
30122786Facilitating the Calculation of the Efficient Score Using Symbolic Computing.Am Stat2018
  • 1 - 50 of 140

Recommended Authors

Mayo Clinic
Career Start Year 2010
Number of shared co-authors 16
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 5
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 2
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 10
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 9
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
University of Dhaka
Career Start Year 2004
Number of shared co-authors 5
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Career Start Year 2004
Number of shared co-authors 8
University of California
Career Start Year 2003
Number of shared co-authors 2
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 40
Queen's University
Career Start Year 2002
Number of shared co-authors 3
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 9
St. Jude Children's Research Hospital.
Career Start Year 2001
Number of shared co-authors 5
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 10
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 15
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 15
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1999
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 11
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 8
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 5
The Ohio State University
Career Start Year 1997
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 10
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 7
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 3
National Cancer Institute
Career Start Year 1975
Number of shared co-authors 5
University of California los angeles
Career Start Year 1970
Number of shared co-authors 19

Collaborators

University of Chicago
Co-authored papers 24
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 18
Co-authored papers 12
University of California San Francisco
Co-authored papers 12
South China University of Technology
Co-authored papers 9
Co-authored papers 8
Japanese Foundation for Cancer Research
Co-authored papers 7
Peking University People's Hospital
Co-authored papers 7
National Cancer Institute
Co-authored papers 7
National Cancer Institute, National Institutes of Health
Co-authored papers 7
Institute for Clinical and Translational Research, Baylor College of Medicine
Co-authored papers 6
University of Toronto Dalla Lana School of Public Health
Co-authored papers 6
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 6
Allergy-Cancer-BioNano Research Centre, University of Salzburg
Co-authored papers 6
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 6
University of Goettingen
Co-authored papers 6
University Medical Center Goettingen
Co-authored papers 6
Duke University School of Medicine
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 4
Stanford University School of Medicine
Co-authored papers 4
Dana Farber Cancer Institute
Co-authored papers 4
Institute and Clinic for Occupational, University Hospital
Co-authored papers 4
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 3
Morehouse School of Medicine
Co-authored papers 3
University of California san francisco
Co-authored papers 3
Vanderbilt University Medical Center
Co-authored papers 3